Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection
Clinical trial NCT04731116 · UNKNOWN
Trial details
- NCT number
- NCT04731116
- Sponsor
- Rabin Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-10
- Primary completion
- 2021-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.